WHO Drug Information Vol. 19, No. 3, 2005
(2005; 72 pages) View the PDF document
Table of Contents
Open this folder and view contentsPersonal Perspectives
Open this folder and view contentsSafety and Efficacy Issues
Open this folder and view contentsHerbal Medicines
Open this folder and view contentsRegulatory Action and News
Close this folderEssential Medicines
Close this folderHighlights of the 14th Model List of Essential Medicines
View the documentMethadone and buprenorphine
View the documentMifepristone with misoprostol
View the documentWHO Model List of Essential Medicines
Open this folder and view contentsAccess to Medicines
Open this folder and view contentsThe International Pharmacopoeia
View the documentRecommended International Nonproprietary Names: List 54
 

Highlights of the 14th Model List of Essential Medicines

The WHO Expert Committee on the Selection and Use of Essential Medicines met in Geneva in March 2005. Their task was to evaluate evidence-based material relating to the maintenance and updating of the Model List of Essential Medicines. The Model List presents a list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost effective medicines for priority conditions. Two important items from the draft report (http://www.who.int/medicines/library/general/1-ReportFinal-unedited_010705.pdf) are presented below and the latest revision of the 14th Model List of Essential Medicines can be found on page 224.

to previous section to next section
 

Last updated: April 24, 2012